FDA Inspection
K.C. Pharmaceuticals, IncK.C. Pharmaceuticals, Inc – FDA Inspection, Jan 30, 2020
Record Details
This FDA Inspection record concerns K.C. Pharmaceuticals, Inc, with an inspection on January 30, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- K.C. Pharmaceuticals, Inc
- Inspection Date
- January 30, 2020
- Product Type
- Drugs
View Company Profile
ID · 78f9da67-71fe-4721-bde3-5e1eb4ee0ad5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1116341
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.101(b)Measured components for manufacturing
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.56(c)Written procedures lacking for use of pesticides etc.
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of K.C. Pharmaceuticals, Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| August 28, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for K.C. Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.